The Healthcare AI Trust Gap Is Now a Marketing Problem

Recent surveys from this spring reveal a clear pattern: AI usage continues to rise, but trust is declining, highlighting a disconnect that needs addressing.

Three surveys this spring tell the same story.

In January 2026, Ohio State Wexner Medical Center polled 1,007 U.S. adults on AI in their care. Openness dropped from 52% in 2024 to 42%. Belief that AI makes health processes more efficient fell from 64% to 55%. That's a 10-point slide in two years.

In February and March, KFF polled 1,343 adults. One in three (32%) had used AI for health information in the past year. 77% said they were concerned about the privacy of their medical data going into these tools. 41% of users had uploaded personal medical information anyway.

In March, Wolters Kluwer and Ipsos surveyed 355 clinicians and 254 patients. 72% of clinicians and 61% of patients said they were concerned that advertiser-driven bias could affect AI-generated health information. 92% of doctors said it was important that a human expert validate AI clinical content before it reaches a patient.

Three different sample frames. One repeated pattern: usage is climbing, trust is falling, and patients are uploading their data into tools they say they don't trust.

For anyone marketing health tech, this is the new operating environment.

The hype cycle, but specifically

There's a quote in the Ohio State release worth holding on to. Dr. Ravi Tripathi, the hospital's chief health informatics officer, calls the trust drop "on par with the natural hype cycle of any kind of technology." Pros and cons get sorted out. The number stabilizes.

That's probably right. But it has a near-term consequence that the marketing departments of health-tech vendors have not caught up to.

The phrase "AI-powered" used to be a feature. Now, it signals to many patients that the platform may prioritize revenue over care, and to clinicians that system guardrails are needed. Recognizing this shift helps marketers empathize with their audience's concerns and adapt messaging accordingly.

What the numbers reward

Read all three studies together and a specific pattern emerges. Patients and clinicians don't object to AI. They object to AI without context.

In the Wolters Kluwer survey, 70% of both groups said they believe AI can improve health literacy and engagement. 92% of doctors and 90% of nurses said they want a human-in-the-loop validating clinical content. KFF found that 65% of AI users cited "quick or immediate information" as a major reason for using the tool — alongside difficulties accessing or affording care.

The signal: there's appetite. There's also a clear list of what people want named.

• Who validated the model.

• What data trained it.

• Where the human checkpoint sits.

• What happens to the input.

• Who pays for the output.

A health-tech brand that names those five things on its homepage is doing something the category mostly isn't.

What this looks like in practice

A few honest moves.

Stop leading with "AI-powered." Lead with what the product does. If the AI part matters, name the model class, the validation, and the human review process. "AI-powered" without that context now reads as marketing for marketing's sake.

Publish your guardrails. Patients already think advertiser-driven bias is creeping into AI tools — 61% of them, per Wolters Kluwer. A short, dated, named-author page describing how you handle data, training, sponsorship, and safety.

Marketing should focus on the audience differently. Clinicians are using AI more often than patients — validation and human review, addressing clinicians' concerns about deskilling and hallucinations, and fostering a sense of safety and responsibility in AI use.

Remember who's already using you. 41% of AI health-info users have uploaded their own medical data into a chatbot. They did it despite the privacy concerns. Trust isn't a precondition for usage anymore. It is, however, a precondition for advocacy and renewal.

The frame to hold

The story playing out in the data is not that AI is over in healthcare. The opposite. Adoption is up. Daily clinician use is up. Patient use is up.

What's down is the assumption that the technology speaks for itself.

That's an old marketing problem in a new format. When the product is novel, "we built it" is enough. When the product is everywhere, the work shifts to "here's what we did, here's who checked it, here's where the line is."

The brands that name those things specifically — with dated content, real authors, and visible governance — get to keep the trust the category is leaking.

The brands still leading with "AI-powered" are about to find out how that sounds in the second half of 2026.